Schedule 13G ownership disclosure

Arcutis Biotherapeutics Inc

COMMON STOCK · CUSIP: 03969K108

Event date: 2026-09-30

Filing-level shares
7,718,628.00
Percent of class
6.1%
  • STATE STREET CORPORATION

    Shares: 7,718,628.00 · Class: 6.1%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000093751-26-000615
Form type
SCHEDULE 13G
Filer
Arcutis Biotherapeutics, Inc.
CIK
CIK 1787306
Filed
Nov 10, 2026
Reporting period
Sep 30, 2026
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub

SCHEDULE 13G | SEC Filings Hub